India has the second-largest capability globally, to manufacture Covid-19 vaccines. Chart from Statista www.statista.com
India has the second-largest capability globally, to manufacture Covid-19 vaccines. Chart from Statista www.statista.com

The morning dailies in India are full of headlines and photos showing the shipments of Covid-19 vaccines rolling out to airports and major cities in a transport cold chain that includes planes and trucks. From the major cities, these will go to smaller towns and centers. The designated hospitals and vaccination centers will start vaccinating front line workers and healthcare staff in the first phase of 3 crore (30 million) vaccinations.

Pune’s Serum Institute of India sent its batches of Covishield (the Oxford-Astrazeneca vaccine) out on Tuesday morning – 12 January 2020. In its 148-page document, the Health and Family Welfare ministry has spelled out the operational guidelines, and the preparations at the hospitals and vaccination centers are mostly in line with these. From the list of those designated for vaccination to issuing an electronic certificate, the entire process is meant to be digital and managed using the Co-Win app.

Katharina Bucholz has written an article for Statista based on data from data analytic company Affinity, stating that the US and India have the two largest capacities to manufacture Covid-19 vaccines till the end of 2021. The US can produce almost 4.7 billion doses, and India can deliver more than 3 billion doses this year.

The largest vaccine manufacturer globally is the Serum Institute of India, which produced 1.5 billion doses in 2015. SII has significantly enhanced its capabilities in the past pandemic year, while some expansion is still underway and likely to be completed in the current year.

The Serum Institute of India plans to produce 1 billion doses of the Oxford-AstraZeneca vaccine, which was rolled out on Tuesday with vaccinations to start by Saturday 16 January 2020. India’s domestically developed vaccine, Covaxin from Bharat Biotech, is also planning to roll out its first 12 million doses, although the stage III trials are not complete. Covaxin is also likely to be the first Indian manufactured Covid-19 vaccine exported. Bharat Biotech has already signed a deal with Precisa Medicamentos to supply the Covid-19 vaccine candidate to Brazil.

India has several other vaccine manufacturers and a more robust cold chain than many observers are aware of. Its pharma industry is well known for ethically supplying vaccines and treatment drugs to emerging countries at affordable prices.

Packaging South Asia — authentic, impactful and influential

An English-language packaging industry B2B platform in print and web, Packaging South Asia is in its 19th year of publication. We do not make any claims about being the best or the most widely read. However, if you are interested in targeting the Indian and South Asian markets to sell equipment, technology, software, and consumables, we can help.

To improve your marketing and grow sales, talk to us. Our research and consulting company IppStar [www.ippstar.org] can assess your potential and addressable markets in light of the competition. We can discuss marketing, communication, and sales strategies for market entry and growth.

Suppliers and service providers with a strategy and budget for targeted marketing can discuss using our hybrid print, web, video, and social media channels to create brand recognition linked to market relevance. Our platform and channels are differentiated by hands-on practice and an understanding of business and financials. Our team, including some of the best technical writers, is ready to meet you and your customers for content.

India and South Asia’s fast-growing packaging industry is continuously expanding capacities with efficiency and appropriate innovative technologies. Get our 2025 media kit and recalibrate your role in this dynamic market. Enhance your visibility and relevance to existing markets and turn potential customers into conversations. Ask for a sample copy of our monthly or two weekly packaging eZines.

For editorial info@ippgroup.in — for advertisement ads1@ippgroup.in and for subscriptions subscription@ippgroup.in

Naresh Khanna – 21 January 2025

Subscribe Now
unnamed 1

NEWSLETTER

Subscribe to our Newsletter

Previous articleThoughtful packaging design improves customer experience
Next articleLook! No dirty hands on your packaging cases and cartons
Naresh Khanna
Editor of Indian Printer and Publisher since 1979 and Packaging South Asia since 2007. Trained as an offset printer and IBM 360 computer programmer. Active in the movement to implement Indian scripts for computer-aided typesetting. Worked as a consultant and trainer to the Indian print and newspaper industry. Visiting faculty of IDC at IIT Powai in the 1990s. Also founder of IPP Services, Training and Research and has worked as its principal industry researcher since 1999. Author of book: Miracle of Indian Democracy. Elected vice-president of the International Packaging Press Organization in May 2023. One of the judges for Packaging Sustainability Awards 2024 and 2025.

LEAVE A REPLY

Please enter your comment!
Please enter your name here